Story thread · 2 reports / 2 sources
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win
endpts.com · 1d
Plus news about Avere Therapeutics, Novo Nordisk, Sobi, Innate Pharma, Oculis, Innovent Biologics and Daiichi Sankyo. 🌏 BeOne gets rights to RevMed drugs in 'select Asian markets': The deal includes Revolution Medicines' four clinical RAS ...
First report: BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration — financialpost.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.